BRPI0509737A - glycosamine and anti-inflammatory mutual glucosamine prodrugs, compositions, and methods - Google Patents

glycosamine and anti-inflammatory mutual glucosamine prodrugs, compositions, and methods

Info

Publication number
BRPI0509737A
BRPI0509737A BRPI0509737-1A BRPI0509737A BRPI0509737A BR PI0509737 A BRPI0509737 A BR PI0509737A BR PI0509737 A BRPI0509737 A BR PI0509737A BR PI0509737 A BRPI0509737 A BR PI0509737A
Authority
BR
Brazil
Prior art keywords
glycosamine
compositions
inflammatory
methods
glucosamine
Prior art date
Application number
BRPI0509737-1A
Other languages
Portuguese (pt)
Inventor
Anthony C Capomacchia
Solomon T Garner Jr
J Warren Beach
Original Assignee
Univ Georgia Res Foudation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgia Res Foudation Inc filed Critical Univ Georgia Res Foudation Inc
Priority claimed from PCT/US2005/011739 external-priority patent/WO2005116086A2/en
Publication of BRPI0509737A publication Critical patent/BRPI0509737A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

GLICOSAMINA E PRó-FáRMACOS MúTUOS ANTI-INFLAMATóRIOS DE GLICOSAMINA, COMPOSIçõES, E MéTODOS. A presente invenção refere-se a pró-fármacos mútuos de glicosamina, e derivados e análogos de glicosamina e um agente antiinflamatório, composições dos mesmos, e métodos para tratar, por exemplo, distúrbios e condições por administração das composições. Também são fornecidas composições tópicas de glicosamina, e derivados e análogos de glicosamina.GLYCOSAMINE AND ANTI-INFLAMMATORY PRODUCT OF ANTI-INFLAMMATORY GLYCOSAMINE, COMPOSITIONS, AND METHODS. The present invention relates to mutual glucosamine prodrugs, and glycosamine derivatives and analogs and an anti-inflammatory agent, compositions thereof, and methods for treating, for example, disorders and conditions by administering the compositions. Topical glycosamine compositions, and glycosamine derivatives and analogs are also provided.

BRPI0509737-1A 2005-04-07 2005-04-07 glycosamine and anti-inflammatory mutual glucosamine prodrugs, compositions, and methods BRPI0509737A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/011739 WO2005116086A2 (en) 2004-04-07 2005-04-07 Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods

Publications (1)

Publication Number Publication Date
BRPI0509737A true BRPI0509737A (en) 2007-09-25

Family

ID=38516101

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509737-1A BRPI0509737A (en) 2005-04-07 2005-04-07 glycosamine and anti-inflammatory mutual glucosamine prodrugs, compositions, and methods

Country Status (1)

Country Link
BR (1) BRPI0509737A (en)

Similar Documents

Publication Publication Date Title
WO2005116086A3 (en) Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
MX2021005087A (en) Methods for treating arenaviridae and coronaviridae virus infections.
BRPI0712631B8 (en) compounds, processes for preparing a compound, pharmaceutical composition, use of a compound and combinations
BRPI0508561A (en) 3-4-Heterocyclyl-1,2,3-triazol-1-yl-n-arylbenzamides as inhibitors of cytokine production for the treatment of chronic inflammatory diseases
BR112014013661A2 (en) 2',4'-DIFLUORO-2'-METHYL DERIVATIVES OF SUBSTITUTED 2',4'-DIFLUORO-2'-METHYL AS INHIBITORS OF HCV-RNA REPLICATION
DOP2006000170A (en) NEW DERIVATIVES OF ESPIROCROMANONA
BRPI0707302B8 (en) cyanoisoquinoline compounds that act on tissue damage associated with ischemia, hypoxia and anemia, as well as pharmaceutical composition comprising them
CR20110077A (en) DIOXA-BICYCLE DERIVATIVES [3.2.1] OCTANO-2,3,4-TRIOL
BRPI0518904A2 (en) typical nepafenac formulations
BRPI0312398B8 (en) substituted 1,3-diphenylprop-2-en-1-one derivative, process for preparing compounds, pharmaceutical composition and use of at least one substituted 1,3-diphenylprop-2-en-1-one derivative
BRPI0610850A2 (en) Aryl alkyl acid derivatives, pharmaceutical composition, medicament as well as use of said derivatives
MX2010001242A (en) Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same.
BR112014003225A2 (en) vehicle-linked treprostinil prodrugs
ECSP078060A (en) 2,4-DIAMINO-PYRIMIDINS AS AURORA INHIBITORS
BRPI0815708B8 (en) compound, prodrug ester, pharmaceutical composition, and, method of treating a disease or condition
CR10192A (en) AMIDO COMPOUNDS AND ITS USE AS PHARMACEUTICAL PRODUCTS
BRPI0607455A2 (en) compound, process for preparing same, use of a compound, and pharmaceutical composition
SE0301010D0 (en) Novel compounds
CY1112429T1 (en) Substituted Sulfonamide Derivatives
UY30220A1 (en) TETRAHYDROPIRIDOTIENOPIRIMIDINA COMPOUNDS AND METHODS FOR USE
BRPI0519521A2 (en) thiene pyridine derivatives as gaba-b allosteric enhancers
SE0301009D0 (en) Novel compounds
BRPI0513278A (en) use of a compound, compound, pharmaceutical composition, process for producing a compound, and method for causing cell death by photon activation therapy
NZ707859A (en) Inhibitors of sodium glucose cotransporter 1
MX2010002210A (en) Catecholamine derivatives and prodrugs thereof.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]